Oncology
Consultant – Medical Oncology14 years of overall medical experience
Manipal Hospitals
Bengaluru
Dr. Sreevalli A is a Consultant Medical Oncologist at Manipal Hospital, Kanakapura Road, Bangalore. She specialises in comprehensive cancer management, including chemotherapy, immunotherapy, targeted therapy, precision oncology and treatment of solid tumours and haematological malignancies. Her clinical expertise includes breast cancer, lung cancer, gastrointestinal cancers, gynecological cancers, urogenital cancers, lymphoma, multiple myeloma and chronic leukemia.
Dr. Sreevalli A completed her MBBS from Sri Shamanur Shivashankarappa Institute of Medical Sciences & Research Centre, Davangere, followed by MD in General Medicine from St. John's Medical College, Bangalore. She subsequently completed DM in Medical Oncology at Kidwai Memorial Institute of Oncology, Bangalore, where she received the Gold Medal for securing the first rank in the state university examination in 2022. She also holds the MRCP (UK) Specialty Certificate in Medical Oncology and ESMO certification.
As a medical oncologist in Bangalore, Dr. Sreevalli provides personalised treatment planning for patients diagnosed with cancer. Her approach involves evaluating pathology reports, cancer stage, imaging findings, molecular markers and the patient's general health before recommending appropriate systemic treatment. Treatment options may include chemotherapy, immunotherapy, targeted therapies and other evidence-based approaches.
Dr. Sreevalli has particular expertise in breast cancer and lung cancer management. She has contributed to clinical research involving metastatic breast cancer and advanced malignancies and was selected for the IASLC Academy 2025 programme in recognition of her interest in lung cancer care. Her experience includes assessment of treatment response, management of therapy-related side effects and ongoing follow-up for patients receiving systemic cancer treatment.
Her clinical interests also include haematological malignancies such as lymphoma, multiple myeloma and chronic leukemia. She evaluates patients requiring systemic anti-cancer therapy and collaborates with other specialists to coordinate care. The treatment plan may include chemotherapy, targeted medicines, immunotherapy or referral for specialised procedures when appropriate.
Dr. Sreevalli is actively involved in precision and molecular oncology. She has completed additional training in cancer genomics and has participated as Co-Principal Investigator in international multicentre oncology trials. Her research interests include molecular profiling of tumours, immunotherapy and real-world outcomes of cancer treatments. These areas support informed treatment decisions based on tumour biology and available clinical evidence.
In addition to cancer-directed treatment, Dr. Sreevalli provides supportive and palliative oncology care. She evaluates treatment-related symptoms, discusses therapy goals and works with multidisciplinary teams to address patients' medical and supportive needs. Her clinical background includes outpatient and inpatient oncology services and management of chemotherapy and immunotherapy pathways.
Dr. Sreevalli has contributed to research publications in recognised oncology journals and has presented at national and international scientific meetings. Her achievements include a DM Medical Oncology Gold Medal, the Best Outgoing Student Award in General Medicine and selection for the IASLC Academy 2025. She is a member of ASCO, ESMO, IASLC and other oncology organisations.
Patients searching for Dr. Sreevalli A, a medical oncologist and cancer specialist in Bangalore, can consult her at Manipal Hospital, Kanakapura Road. She provides specialist evaluation for solid tumours, blood cancers, chemotherapy, immunotherapy and personalised cancer treatment. Appointment availability and consultation fees should be confirmed directly with the hospital.
Dr. Sreevalli A provides medical oncology consultations for breast cancer, including locally advanced and metastatic disease. Treatment may involve chemotherapy, hormonal therapy, targeted medicines or immunotherapy according to tumour characteristics. HER2 status, hormone receptor status, cancer stage and previous treatment are important considerations when planning systemic therapy.
Dr. Sreevalli A has a documented interest in lung cancer management and was selected for the IASLC Academy 2025. Lung cancer treatment depends on the tumour type, stage and molecular characteristics. Appropriate options may include chemotherapy, targeted therapy, immunotherapy and coordinated care with radiation and surgical oncology specialists.
Chemotherapy uses medicines to destroy cancer cells or limit their growth. Dr. Sreevalli A has experience managing chemotherapy pathways for patients with solid tumours and blood cancers. Treatment selection depends on the cancer diagnosis, intended treatment goals, organ function and potential side effects.
Immunotherapy helps the immune system recognise or respond to certain cancers. Dr. Sreevalli A specialises in immunotherapy as part of medical oncology care. Eligibility depends on the cancer type, treatment history, biomarkers and overall medical condition. Potential immune-related side effects require monitoring.
Targeted cancer therapies act on specific biological pathways or molecular alterations involved in tumour growth. Dr. Sreevalli A has expertise in targeted therapy and molecular oncology. Treatment decisions may require biomarker testing and careful review of clinical evidence for the patient's cancer type.
Precision oncology uses information about tumour biology to help guide treatment. Dr. Sreevalli A has additional training in cancer genomics and an academic interest in molecular profiling. Selected patients may benefit from biomarker or genomic testing when the results can meaningfully inform treatment decisions.
Metastatic cancer occurs when malignant cells spread beyond the original tumour site. Dr. Sreevalli A has participated in clinical research involving advanced malignancies. Management may include systemic therapy, symptom control, monitoring of treatment response and multidisciplinary assessment according to individual treatment goals.
Lymphoma is a cancer affecting lymphocytes and the lymphatic system. Dr. Sreevalli A's official expertise includes lymphoma management. Treatment depends on the lymphoma subtype and may involve chemotherapy, immunotherapy, targeted agents or referral for other specialised haematological treatments.
Multiple myeloma is a cancer involving plasma cells in the bone marrow. Dr. Sreevalli A provides medical oncology assessment for myeloma. Management may include combinations of targeted medicines, immunomodulatory therapies and supportive treatment, with specialist referral for transplantation when appropriate.
Chronic leukemias are blood cancers that may progress at different rates depending on their subtype. Dr. Sreevalli A's clinical expertise includes chronic leukemia. Evaluation involves blood investigations, disease classification and assessment of whether observation or systemic treatment is indicated.
Dr. Sreevalli A provides medical oncology consultation for gynecological malignancies, including ovarian cancer. Systemic treatment may involve chemotherapy, maintenance therapy or targeted medicines in selected patients. Decisions depend on tumour pathology, surgical findings, molecular markers and treatment history.
Cervical and uterine cancers may require multidisciplinary treatment involving surgery, radiotherapy and systemic medicines. Dr. Sreevalli A evaluates patients who may benefit from chemotherapy, immunotherapy or other medical oncology treatments. The approach is based on disease stage, pathology and current clinical recommendations.
Colorectal cancer affects the colon or rectum. Medical oncology treatment may include chemotherapy, targeted therapy or immunotherapy for eligible patients. Dr. Sreevalli A's clinical interests include gastrointestinal cancers, with treatment decisions informed by disease stage and relevant tumour biomarkers.
Gastrointestinal cancers may affect the stomach, oesophagus and other digestive organs. Dr. Sreevalli A provides medical oncology assessment for these malignancies. Systemic treatment may be recommended before surgery, after surgery or for advanced disease, depending on the clinical diagnosis.
Dr. Sreevalli A's documented expertise includes kidney and other urogenital cancers. Selected patients may receive targeted medicines, immunotherapy or other systemic treatments. Medical oncology care is coordinated with urologists, surgical oncologists and other specialists according to the cancer stage.
Systemic treatment for advanced prostate cancer may involve androgen deprivation therapy, hormonal agents, chemotherapy or selected targeted treatments. Dr. Sreevalli A has participated in clinical research involving prostate cancer. Treatment selection depends on disease extent, previous therapy and patient-specific factors.
Head and neck cancers may require chemotherapy, immunotherapy or targeted medicines alongside surgery or radiotherapy. Dr. Sreevalli A has contributed to research involving induction chemotherapy for locally advanced head and neck cancer. Treatment planning considers tumour location, stage and functional outcomes.
Supportive and palliative oncology focuses on relieving symptoms, managing treatment-related problems and improving quality of life. Dr. Sreevalli A has experience with palliative care pathways. Supportive treatment may be provided alongside cancer-directed therapy and adapted to the patient's needs and preferences.
MBBS, MD (General Medicine), DM (Medical Oncology), MRCP (UK) – SCE (Medical Oncology), ESMO Certification
Breast cancer treatment, lung cancer treatment, kidney cancer treatment, prostate cancer treatment, bladder cancer management, ovarian cancer treatment, cervical cancer treatment, uterine cancer management, gastrointestinal cancer treatment, colorectal cancer treatment, stomach cancer treatment, pancreatic cancer consultation, head and neck cancer treatment, lymphoma treatment, multiple myeloma management
Genuine patient experiences and treatment feedback.
Quick answers to common questions about Dr. Sreevalli A
Dr. Sreevalli A is a Consultant Medical Oncologist at Manipal Hospital, Kanakapura Road, Bangalore. Her expertise includes solid tumours, blood cancers, chemotherapy, immunotherapy, targeted therapy and precision oncology.
She holds MBBS, MD in General Medicine and DM in Medical Oncology. She also holds the MRCP (UK) Specialty Certificate in Medical Oncology and ESMO certification.
14 years of overall medical experience, while MediBuddy reports 11 years. The exact figure should be verified before publishing her profile.
Yes. Her official Manipal Hospitals profile confirms expertise in chemotherapy, immunotherapy and targeted cancer therapies.
Yes. Breast and lung cancers are among her documented clinical interests. She has also participated in cancer research and international educational programmes related to these conditions.
Contact us for personalized help or to schedule an appointment.